Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

被引：0
|
作者：
Carlat, Daniel J. [1 ]
机构：
[1] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
PSYCHOPHARMACOLOGY BULLETIN | 2007年 / 40卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：29 / 31
页数：3
相关论文
共 50 条
  • [1] Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
    Robinson, Donald S.
    Gilmor, Michelle L.
    Yang, Ying
    Moonsammy, George
    Azzaro, Albert J.
    Oren, Dan A.
    Campbell, Bryan J.
    PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (03) : 15 - 28
  • [2] Treatment effects of selegiline transdermal system on symptoms of MDD: A meta-analysis of placebo-controlled efficacy trials
    Robinson, Donald
    Gilmor, Michelle L.
    Yang, Ying
    MoonsamMy, George I.
    Azzaro, Albert J.
    Oren, Dan A.
    Campbell, Bryan
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 232S - 232S
  • [3] Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials
    Pae, Chi-Un
    Patkar, Ashwin A.
    Jang, Saeheon
    Portland, Kimberly B.
    Jung, Sungwon
    Nelson, J. Craig
    CNS SPECTRUMS, 2014, 19 (04) : 324 - 329
  • [4] Selegiline transdermal system for the treatment of major depressive disorder: A symptom-based analysis of placebo controlled efficacy trials
    Robinson, Donald
    Gilmor, Michelle
    Eudicone, James
    Moonsammy, George
    Azzaro, Albert
    Oren, Daniel
    Campbell, Bryan
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S108 - S108
  • [5] Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder
    Pae, Chi-Un
    Wang, Sheng-Min
    Han, Changsu
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Praksh S.
    Serretti, Alessandro
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2015, 40 (03): : 174 - 186
  • [6] Efficacy and safety of selegiline transdermal system for atypical depression: pooled analysis of short-term placebo-controlled trials
    Patkar, A. A.
    Jang, S.
    Portland, K.
    Jung, S.
    Pae, C.
    Nelson, J. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S257 - S258
  • [7] The efficacy of vortioxetine in the treatment of patients with major depressive disorder (MDD) in short-term placebo-controlled studies: a meta-analysis of 11 studies
    Vieta, E.
    Loft, H.
    Mahableshwarkar, A. R.
    Florea, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S465 - S466
  • [8] Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials
    Lisa Holper
    Michael P. Hengartner
    BMC Psychiatry, 20
  • [9] Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials
    Holper, Lisa
    Hengartner, Michael P.
    BMC PSYCHIATRY, 2020, 20 (01)
  • [10] A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
    Thase, Michael E.
    Mahableshwarkar, Atul R.
    Dragheim, Marianne
    Loft, Henrik
    Vieta, Eduard
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (06) : 979 - 993
12345